Two Sigma Securities’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,100
Closed -$300K 3093
2023
Q2
$300K Buy
8,100
+900
+13% +$31.4K ﹤0.01% 1882
2023
Q1
$225K Buy
+7,200
New +$232K ﹤0.01% 1982
2022
Q3
Sell
-12,300
Closed -$671K 2758
2022
Q2
$671K Buy
12,300
+5,500
+81% +$302K 0.02% 723
2022
Q1
$424K Buy
+6,800
New +$448K 0.01% 1128

Other funds holding FLGT

Two Sigma Securities's FLGT Position: Q1 2023 in Review

Two Sigma Securities sold out of Fulgent Genetics (FLGT) in Q1 2023, closing a stake of 7,387 shares — an estimated $238K sold.

Two Sigma Securities first reported a position in FLGT in Q4 2022 and held it in 1 quarter. The position peaked at $220K in Q4 2022. 215 funds tracked by Wall St. Rank hold FLGT as of Q1 2023.

  • Two Sigma Securities reported no remaining Fulgent Genetics position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Securities sold 7,387 Fulgent Genetics shares in Q1 2023, an estimated $238K.
  • Two Sigma Securities first reported a position in Fulgent Genetics in Q4 2022 and held it in 1 quarter.
  • Two Sigma Securities's Fulgent Genetics position peaked at $220K in Q4 2022.
  • 215 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.